Antitumor effects of bis-thiosemicarbazones--inhibition of deoxyribonucleic acid synthesis in vitro.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000037:antagonists & inhibitors; D002250:Carbon Radioisotopes; D002478:Cells, Cultured; D002614:Chelating Agents / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology; D003300:Copper / Q000494:pharmacology; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D004353:Drug Evaluation, Preclinical; D004926:Escherichia coli / Q000378:metabolism; D006571:Heterocyclic Compounds / Q000494:pharmacology; D006868:Hydrolysis; D007930:Leucine / Q000378:metabolism; D007939:Leukemia L1210 / Q000378:metabolism; D051379:Mice; D009532:Nickel / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013882:Thiosemicarbazones / Q000494:pharmacology*; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000970:Antineoplastic Agents; D001426:Bacterial Proteins; D002250:Carbon Radioisotopes; D002614:Chelating Agents; D004273:DNA, Neoplasm; D006571:Heterocyclic Compounds; D013882:Thiosemicarbazones; D003035:Cobalt; D003300:Copper; D009532:Nickel; D007930:Leucine; D013936:Thymidine; D014529:Uridine